21.20Class

21.20 Manufacture of pharmaceutical preparations

Financial AggregatesFY 2024

€33,178,250

Total Revenue

313

Employees

€34,828,691

Total Assets

€22,930,463

Total Equity

15.7%

Profit Margin

22.7%

ROE

€106,001

Revenue / Employee

€109,366

Median Revenue

1.5

Median Employees

€133,887

Median Assets

€36,540

Median Equity

3.4%

Median Profit Margin

8.9%

Median ROE

#	Company	Total Revenue	Employees	Profit Margin
1	Sabiedrība ar ierobežotu atbildību "LMP"	€6,027,640	19	47.3%
2	AS "RĪGAS FARMACEITISKĀ FABRIKA"	€5,636,518	75	18.5%
3	SIA "SILVANOLS"	€5,279,088	52	3.4%
4	SIA "Lotos Pharma"	€4,486,102	34	17.1%
5

Showing 1–37 of 37 companies

#	Company	Regcode	Type	Year
1	Amgen Switzerland AG Rīgas filiāle	40003664634	AKF	2024
2	AS "RĪGAS FARMACEITISKĀ FABRIKA"	40003000765	AS	2024
3	"BioLaser" SIA	40203469223	SIA	2024
4	IK "RIŅĶIS G"	44102024720	IK	2023
5	Liepājas speciālās ekonomiskās zonas SIA "NordePlast"	42103074684	SIA

NACE Rev.2/2.1, VID tax data 2022–2024